Similar articles

• [Therapy with antithrombin III in burned children--pilot study].

  Del Principe D, Pietrantoni R, Menichelli A, Siviero MC, Luzi F, Colucci C, Orsini D. Del Principe D, et al. Haematologica. 1990 Mar-Apr;75 Suppl 2:33-40. Haematologica. 1990. PMID: 2387549 Italian. No abstract available.
• Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.

  Jespersen J, Rasmussen NR, Sidelmann J. Jespersen J, et al. Acta Chir Scand Suppl. 1982;509:105-7. Acta Chir Scand Suppl. 1982. PMID: 6962611 No abstract available.
• [Substitution therapy using antithrombin III concentrate].

  Thaler E, Lechner K. Thaler E, et al. Dtsch Med Wochenschr. 1982 Jan 29;107(4):147-9. doi: 10.1055/s-2008-1069889. Dtsch Med Wochenschr. 1982. PMID: 7056170 German. No abstract available.
• [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].

  Sobczyk J, Swietliński J, Podleśny-Owsińska T. Sobczyk J, et al. Pol Tyg Lek. 1989 Oct 2-16;44(40-42):896-8. Pol Tyg Lek. 1989. PMID: 2487947 Review. Polish. No abstract available.
• Antithrombin (AT) substitution: sense or nonsense?

  Köhler M. Köhler M. Anaesthesia. 1998 May;53 Suppl 2:52-4. doi: 10.1111/j.1365-2044.1998.tb15155.x. Anaesthesia. 1998. PMID: 9659067 Review. No abstract available.